Monkeypox Perspective

• Painful Genital Lesions The patient reports fever, chills, and myalgia.
  Medscape, December 03, 2024
• How to Stay Safe When Caring for Patients With Mpox Prompt identification of suspected mpox cases is a vital first step to maintaining workforce safety, experts said at a WHO webinar.
  Medscape Infectious Diseases, November 12, 2024
• Rapid Review Quiz: Mpox Rising Are you prepared to spot and treat mpox in your patients? Test yourself with this quick quiz.
  Medscape, October 02, 2024
• Visual Findings of 9 Sexually Transmitted Infections Sexually transmitted infections (STIs) are a common occurrence, but many lesions can be readily mistaken for other diseases. Can you make an accurate diagnosis in these conditions?
  August 26, 2024
• Cutaneous and Mucosal Manifestations of Viral Diseases Viral infections can cause a range of cutaneous and mucosal manifestations, from isolated lesions to generalized exanthems. Learn more about the findings associated with various viruses.
  February 27, 2024
• Mpox-Associated Hospitalization Among JYNNEOS Vaccinated Persons Even a single dose of JYNNEOS vaccine reduced mpox-associated hospitalization rates compared with those who were unvaccinated, according to this CDC study,
  Morbidity & Mortality Weekly Report, November 17, 2023
• Mpox Patients Without Reported Male-to-Male Sexual Contact Approximately 30% of U.S. mpox patients did not report male-to-male sexual contact. What other routes of mpox exposure were possible in these cases?
  Morbidity & Mortality Weekly Report, November 08, 2023
• Epidemiologic and Clinical Features of Mpox in Adults >50 Years While childhood smallpox vaccination may provide some protection against mpox, adults at risk for mpox, regardless of smallpox vaccination status, should receive the mpox vaccine.
  Morbidity & Mortality Weekly Report, October 27, 2023
• An Mpox Cluster Affecting Persons Previously Vaccinated In this unusual cluster of mpox cases, a large number of cases had been vaccinated with mpox vaccine.
  Morbidity & Mortality Weekly Report, September 04, 2023
• Isolated Ocular Mpox Without Skin Lesions, United States In this case, a patient presented with ocular manifestations of mpox without skin lesions, an uncommon occurrence.
  Emerging Infectious Diseases, August 31, 2023
• Treatment Failure in Severe Mpox Patient With Untreated HIV In this case, mpox treatments were rendered ineffective in a patient with untreated HIV, highlighting the importance of initiating ART at the time of diagnosis.
  Emerging Infectious Diseases, August 29, 2023
• Exposures to Mpox Among Cases in Children Aged Under 12 Years While rare, this report identified 45 cases of mpox among children 12 and under during the recent outbreak. What might be their possible mpox exposure routes?
  Morbidity & Mortality Weekly Report, August 21, 2023
• How the Modern ICU Was Galvanized By a Polio Epidemic   The medical and dental students who kept polio patients alive by hand-ventilating them around the clock are among the cast of characters in this incredible story.
  Medscape, August 15, 2023
• Urban and Rural Mpox Incidence Among Persons Aged 15-64 Years This study analyzed the urbanicity of mpox cases during the 2022 outbreak. How were cases distributed among rural and urban populations?
  Morbidity & Mortality Weekly Report, August 04, 2023
• Mpox Among Public Festival Attendees, Chicago, Illinois An mpox outbreak among people who attended a festival highlights the importance of vaccination prior to large public events.
  Emerging Infectious Diseases, August 03, 2023
• Potential for Recurrent Mpox Outbreaks Among MSM Mathematical modeling underscores the need for sustained monkeypox vaccination services among men who have sex with men in order to protect against a resurgence of mpox.
  Morbidity & Mortality Weekly Report, August 02, 2023
• Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox The findings in this report support the recommended 2-dose JYNNEOS vaccination against Mpox, consistent with CDC guidance.
  Morbidity & Mortality Weekly Report, July 31, 2023
• Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox This real-world assessment of JYNNEOS vaccine effectiveness during the 2022 mpox outbreak found it 75.2% effective for partial vaccination and 85.9% for full vaccination.
  Morbidity & Mortality Weekly Report, July 28, 2023
• Differential Diagnosis, Prevention, and Treatment of mpox Dermatologists are often the first to see suspected mpox cases. Review its differential diagnosis, mode of transmission, prevention, and available treatments in this paper.
  American Journal of Clinical Dermatology, July 14, 2023
• S2 Episode 5: HIV, Primary Care Treatment, and Vaccines   Drs Michael S. Saag and David H. Spach discuss HIV and the nuances of primary care treatment, with a special focus on vaccines, including COVID, hepatitis, varicella zoster virus, and mpox.
  Medscape, July 13, 2023